Quick Answer
RIGEL PHARMACEUTICALS INC reported Total Assets of $513.59 million for the year ending 2025.
- RIGEL PHARMACEUTICALS INC showed an increase of +213.2% in Total Assets from 2024 to 2025.
- This data is from RIGEL PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $289.87 million | Q3 2011: $275.87 million | Q1 2012: $233.91 million | Q2 2012: $214.36 million | Q3 2012: $194.32 million | Q1 2013: $282.94 million | Q2 2013: $261.67 million | Q3 2013: $239.54 million | Q1 2014: $203.29 million | Q2 2014: $182.43 million | Q3 2014: $163.22 million | Q1 2015: $165.69 million | Q2 2015: $148.35 million | Q3 2015: $139.17 million | Q1 2016: $108.28 million | Q2 2016: $99.32 million | Q3 2016: $88.64 million | Q1 2017: $101.33 million | Q2 2017: $85.48 million | Q3 2017: $71.25 million | Q1 2018: $98.81 million | Q2 2018: $141.22 million | Q3 2018: $123.17 million | Q1 2019: $172.78 million | Q2 2019: $156.16 million | Q3 2019: $156.06 million | Q1 2020: $143.36 million | Q2 2020: $138.04 million | Q3 2020: $123.06 million | Q1 2021: $215.99 million | Q2 2021: $201.60 million | Q3 2021: $186.52 million | Q1 2022: $149.07 million | Q2 2022: $128.00 million | Q3 2022: $115.61 million | Q1 2023: $123.61 million | Q2 2023: $117.09 million | Q3 2023: $115.32 million | Q1 2024: $126.52 million | Q2 2024: $128.41 million | Q3 2024: $139.42 million | Q1 2025: $175.97 million | Q2 2025: $206.74 million | Q3 2025: $242.53 million.
- Over the full 16 years of available data (2010 to 2025), RIGEL PHARMACEUTICALS INC's Total Assets has grown by 175.1%.
- Historical annual values: Fiscal year 2025: $513.59 million | Fiscal year 2024: $163.98 million | Fiscal year 2023: $117.23 million | Fiscal year 2022: $134.28 million | Fiscal year 2021: $167.33 million | Fiscal year 2020: $110.38 million | Fiscal year 2019: $147.57 million | Fiscal year 2018: $139.11 million | Fiscal year 2017: $119.11 million | Fiscal year 2016: $78.13 million | Fiscal year 2015: $131.75 million | Fiscal year 2014: $154.14 million | Fiscal year 2013: $226.06 million | Fiscal year 2012: $310.04 million | Fiscal year 2011: $257.11 million | Fiscal year 2010: $186.70 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: